Skip to content

Comparison between the Golghand majun and Polyethylene glycol in the pediatric constipation

Comparative evaluation between the Golghand majun (Rosa damascena) and Polyethylene glycol (4000) in the pediatric functional constipation in chidren 2 to 15 years old referred to Emam Hossein hospital in 2019-2020

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190410043224N1
Enrollment
60
Registered
2020-02-20
Start date
2020-02-20
Completion date
Unknown
Last updated
2020-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional constipation. Other constipation

Interventions

Intervention 1: Golghand majun (Barij Pharmaceutical Company) 500 mg / kg divided in three times daily, orally half an hour before meals for eight weeks. Intervention 2: Control group: Polyethylene g

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 15 Years

Inclusion criteria

Inclusion criteria: Functional constipation confirmed by ROMAN criteria 4 Stool elimination twice a week or less History of stool retention Stiff or painful intestinal function History of large stool diameter History of large stool mass in rectum

Exclusion criteria

Exclusion criteria: Patients with causes of organic constipation such as celiac disease, pseudo-obstruction, hypothyroidism, spinabifida, anorectal malformation, hirschsprung's disease Patients with chronic illness who need special care such as: stone kidney, sickle cell anemia, cereberal palsy, hepatitis, hematologic diseases, gastrointestinal bleeding, relapse fever or fever without locolized sign Pregnanccy History of surgery involvig the gastrointestinal tract exept for appendectomy History of allergies or drug allergies Diagnosis of autism, major psychosis disorder such as bipolar disorder, schizophrenia, children who have experienced physical abuse and sexual abuse Use of medication such as Metoclopyramide, Erythromycin, Butanol, Amoxiclav, Azithromycin, Domperidone, Amitriptyline, Hyoscyamine, Clonidine, Baclofen, Dicyclomine, Scopolamine Weight loss over five percent in the past three monthes Use of drugs that have an unknown delay in the gastrointestinal tract

Design outcomes

Primary

MeasureTime frame
Constipation improvement. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: Clinical Examination; Questionnaire of Constipation Evaluation.

Secondary

MeasureTime frame
Treatment side effects. Timepoint: During the study and 8 weeks after the intervention. Method of measurement: Clinical Examination; Questionnaire of Constipation Evaluation.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSaeedeh Ghaedi

Esfahan University of Medical Sciences

Ghaedi_saeedeh@yahoo.com+98 31 3386 6266

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026